Clinical trial
Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney…
NCT00045318 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00045318 |
|---|---|
| Title | Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction |
| Official title | A Phase I Study of DX-8951f (Exatecan Mesylate for Injection) in Patients With Renal Dysfunction |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | exatecan mesylate |
| Start date | May 1, 2002 |
| Completion | Oct 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: